Close
Close

Medical testing company engaged in active trade or business for purposes of Section 1202

RFP
Tax Hot Topics: Medical testing company engaged in active trade or business for purposes of Section 1202The IRS recently issued a private letter ruling (PLR 201717010), in which it determined that a corporation that uses proprietary technology to perform certain medical tests is engaged in a qualified trade or business for purposes of Section 1202.

In general, Section 1202(a) provides that gross income does not include some or all of the gain from the sale or exchange of qualified small business stock (QSBS) held for more than five years. The gain exclusion under Section 1202 is 50% for stock acquired before Feb. 18, 2009, 75% for stock acquired between Feb. 19, 2009, and Sept. 27, 2010, and 100% for stock acquired on or after Sept. 28, 2010.

Generally, QSBS is defined as stock of a qualified small business. One of the requirements a corporation must meet to be considered a qualified small business is that at least 80% of its assets are used in the active conduct of one or more qualified trades or businesses. Certain businesses are statutorily disqualified as active trades or businesses, including those involving the performance of services in the field of health and those in which the principal asset is the reputation or skill of one or more of its employees.

In the facts of the PLR, the company developed a proprietary tool to perform certain medical tests. The company’s employees analyze the results of the tests and prepare laboratory reports for healthcare providers. Those laboratory reports do not diagnose or recommend treatment, and the company does not discuss diagnosis or treatment with patients or with the healthcare providers who commission the tests. The IRS noted that the company’s employees are well educated, but the  pre-existing skills  they bring to the company are not useful to the company in performing its particular medical tests.

Noting the lack of diagnosis or treatment services performed by the company, as well as the fact that the skills of the company’s employees are not useful to other employers, the IRS determined that the company “is not in a trade or business (i) involving the performance of services in the field of health or (ii) where the principal asset of the trade or business is the reputation or skill of one or more of its employees.” Based on that determination, it concluded that the company was engaged in a qualified trade or business for purposes of Section 1202.

Thus, the company satisfied the qualified trade or business test, and to the extent the company and its shareholders otherwise satisfied the remaining requirements under Section 1202, such shareholders would be eligible to exclude some or all of their gain from the disposition of the company’s stock.

Contact
Andy Cordonnier
Partner, Washington National Tax Office
T +1 202 521 1502

Bryan Keith
Managing Director, Washington National Tax Office
T +1 202 861 4116

Tax professional standards statement
This content supports Grant Thornton LLP’s marketing of professional services and is not written tax advice directed at the particular facts and circumstances of any person. If you are interested in the topics presented herein, we encourage you to contact us or an independent tax professional to discuss their potential application to your particular situation. Nothing herein shall be construed as imposing a limitation on any person from disclosing the tax treatment or tax structure of any matter addressed herein. To the extent this content may be considered to contain written tax advice, any written advice contained in, forwarded with or attached to this content is not intended by Grant Thornton LLP to be used, and cannot be used, by any person for the purpose of avoiding penalties that may be imposed under the Internal Revenue Code.

The information contained herein is general in nature and is based on authorities that are subject to change. It is not, and should not be construed as, accounting, legal or tax advice provided by Grant Thornton LLP to the reader. This material may not be applicable to, or suitable for, the reader’s specific circumstances or needs and may require consideration of tax and nontax factors not described herein. Contact Grant Thornton LLP or other tax professionals prior to taking any action based upon this information. Changes in tax laws or other factors could affect, on a prospective or retroactive basis, the information contained herein; Grant Thornton LLP assumes no obligation to inform the reader of any such changes. All references to “Section,” “Sec.,” or “§” refer to the Internal Revenue Code of 1986, as amended.